BioSpace News Archive

Pharm Country

Johnson & Johnson Vision Announces TearScience LipiScan and LipiFlow Now Available in More Than 800 Eye Care Practices to Image Meibomian Glands and Treat Meibomian Gland Dysfunction

Meibomian Gland Dysfunction (MGD) is a primary cause of dry eye disease, which impacts more than 340 million people globally.

November 9, 2017

·

3 min read

Optovue Highlights AngioVue Essential OCTA at AAO

AAO attendees can see Optovue’s suite of advanced eye care products including the new AngioVue Essential OCTA capability in booth #3126.

November 9, 2017

·

2 min read

Policy

Fujifilm Receives Innovative Technology Designation From Vizient for Its Digital Radiography Solutions Including the FDR AQRO and FDR D-EVO GL Panel

The designations were based on direct feedback from hospital clinicians who interacted with the FDR AQRO and FDR D-EVO GL Panel at the Vizient Innovative Technology Exchange in Denver, Colo. on September 14, 2017.

November 9, 2017

·

4 min read

Business

Idengene SA to Bring Contextual Genomics’ Revolutionary Cancer Genomic Test Find-It™ to Brazil

Idengene SA has partnered with leading Canadian cancer genomics company Contextual Genomics to bring Find-It, a potentially revolutionary genomic test, to Brazil.

November 9, 2017

·

4 min read

Biotech Beach

AcuFocus Release: KAMRA Corneal Inlay Delivers Uncompromised Vision for Presbyopic Patients

With the KAMRA inlay, you can restore your reading vision while maintaining great distance vision by extending your overall depth of focus.

November 9, 2017

·

4 min read

Business

Fraunhofer ITEM in New Research Alliance: Bacteriophages Join the Fight Against Infection

The goal is to establish bacteriophages as an approved drug for treating bacterial infections.

November 9, 2017

·

3 min read

Pharm Country

AmerisourceBergen Increases Dividend 4 Percent

The Board of Directors of AmerisourceBergen Corporation today increased the Company’s quarterly dividend rate 4 percent to $0.38 per common share from $0.365 per common share.

November 9, 2017

·

5 min read

Business

GeoVax Reports 2017 Third Quarter Financial Results and Development Program Updates

GeoVax reported a net loss of $588,787 ($0.01 per share) for the three months ended September 30, 2017, compared to $464,200 ($0.01 per share) for the same period in 2016.

November 9, 2017

·

15 min read

Business

Alcami Announces Manufacturing Agreement for Solasia’s Active Pharmaceutical Ingredient Darinaparsin

The company has finalized manufacturing and quality agreements with Solasia Pharma, K.K.

November 9, 2017

·

2 min read

Genetown

Brooks Life Sciences Bolsters Bioprocessing Capabilities Through Expansion of Sample Preparation Services in Germany

The company has expanded its sample preparation and bioprocessing laboratory service.

November 9, 2017

·

3 min read